Просмотры

Аннотация: 3605

PDF (Английский): 595

Cited-by

1. Gasperi R.D., Garcia G.P., Sosa M., и др. Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure // Frontiers in Neurology. - 2025. - Т. 16. doi: 10.3389/fneur.2025.1594335
2. Wasti A.Z. Psychedelic Drugs - Therapeutic and Recreational Use [Working Title] Psychedelics’ Intoxicating Impact and Behavioural Dynamics // - 2025. doi: 10.5772/intechopen.1011743
3. Werle I., Bertoglio L.J. Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents // Neuroscience & Biobehavioral Reviews. - 2024. - Т. 167. - С. 105899. doi: 10.1016/j.neubiorev.2024.105899
4. Modlin N.L., Williamson V., Maggio C., и др. Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework // Therapeutic Advances in Psychopharmacology. - 2025. - Т. 15. doi: 10.1177/20451253251342319
5. Kargbo R.B. Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine // ACS Medicinal Chemistry Letters. - 2024. - Т. 15. - №9. - С. 1443. doi: 10.1021/acsmedchemlett.4c00414
6. Jones N., Frost E. Ketamine: New Uses for an Old Drug? // Topics in Pain Management. - 2025. - Т. 40. - №8. - С. 1. doi: 10.1097/01.TPM.0001108044.62000.1d
7. Brizzi G., Pupillo C., Rastelli C., и др. Cyberdelics: Virtual reality hallucinations modulate cognitive-affective processes // Dialogues in Clinical Neuroscience. - 2025. - Т. 27. - №1. - С. 1. doi: 10.1080/19585969.2025.2499459
8. Fakhrudin A., Munawaroh A., Donal ., и др. Depression recovery: Untangling the effects of childhood trauma // General Hospital Psychiatry. - 2025. - Т. 93. - С. 54. doi: 10.1016/j.genhosppsych.2025.01.008
9. Carter C.S. The psychedelic-peptide paradox: a hormetic hypothesis // Comprehensive Psychoneuroendocrinology. - 2025. - Т. 23. - С. 100303. doi: 10.1016/j.cpnec.2025.100303
10. Yates J. Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets // Substance Abuse and Rehabilitation. - 2024. - Т. Volume 15. - С. 125. doi: 10.2147/SAR.S431273
11. Bouloufa A., Delcourte S., Haddjeri N. Mécanismes d’action et perspectives thérapeutiques du LSD : état des lieux actuel // Biologie Aujourd’hui. - 2025. - Т. 219. - №1-2. - С. 89. doi: 10.1051/jbio/2025008
12. Low Z., Yong S.J., Alrasheed H.A., и др. Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review // Progress in Neuro-Psychopharmacology and Biological Psychiatry. - 2025. - Т. 137. - С. 111279. doi: 10.1016/j.pnpbp.2025.111279
13. Viohl N., Zanjani A., Khandelia H. Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqα // FEBS Letters. - 2025. - Т. 599. - №6. - С. 876. doi: 10.1002/1873-3468.15099
14. Banushi B., Collova J., Milroy H. Epigenetic Echoes: Bridging Nature, Nurture, and Healing Across Generations // International Journal of Molecular Sciences. - 2025. - Т. 26. - №7. - С. 3075. doi: 10.3390/ijms26073075
15. Agorastos A. Thematic Selection: Stress and Stress-related Disorders Posttraumatic Stress Disorder (Part 2) // Current Neuropharmacology. - 2024. - Т. 22. - №4. - С. 522. doi: 10.2174/1570159X2204231106143917
16. Shannon S., Geller J. MDMA for PTSD and beyond: a new paradigm brings hope // Frontiers in Human Neuroscience. - 2024. - Т. 18. doi: 10.3389/fnhum.2024.1475013
17. Kinderlehrer D. Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity // Neuropsychiatric Disease and Treatment. - 2025. - Т. Volume 21. - С. 141. doi: 10.2147/NDT.S500337
18. Villalba S., Bosch S., Constanzo L.D., и др. Noribogaine altered intrinsic properties of thalamocortical neurons in a sex-dependent manner // Progress in Neuro-Psychopharmacology and Biological Psychiatry. - 2025. - С. 111467. doi: 10.1016/j.pnpbp.2025.111467
19. Herpers J., Maximets N., Dongen N., и др. Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation // European Journal of Psychotraumatology. - 2024. - Т. 15. - №1. doi: 10.1080/20008066.2024.2378651
20. Kriegman D., Pelletier R., Griggs C., Roth C. Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD // Contemporary Clinical Trials Communications. - 2025. - Т. 45. - С. 101451. doi: 10.1016/j.conctc.2025.101451
21. Mauney E., King F., Burton-Murray H., Kuo B. Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome // Journal of Clinical Gastroenterology. - 2025. - Т. 59. - №5. - С. 385. doi: 10.1097/MCG.0000000000002149